NRG/GOG 186K: A randomized phase II study of NCI-supplied cabozantinib versus weekly paclitaxel in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer—Final results

2016 ◽  
Vol 141 ◽  
pp. 207 ◽  
Author(s):  
U.A. Matulonis ◽  
M. Sill ◽  
P.H. Thaker ◽  
J.W. Carlson ◽  
C.J. Darus ◽  
...  
Keyword(s):  
Fallopian Tube ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Weekly Paclitaxel ◽  
Primary Peritoneal Cancer ◽  
Peritoneal Cancer ◽  
Randomized Phase Ii

scholarly journals A phase II study of GM-CSF and rIFN-γ1b plus carboplatin for the treatment of recurrent, platinum-sensitive ovarian, fallopian tube and primary peritoneal cancer

2009 ◽  
Vol 113 (2) ◽  
pp. 210-215 ◽  
Author(s):  
Kathleen M. Schmeler ◽  
Saroj Vadhan-Raj ◽  
Pedro T. Ramirez ◽  
Sachin M. Apte ◽  
Lorenzo Cohen ◽  
...  
Keyword(s):  
Fallopian Tube ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Primary Peritoneal Cancer ◽  
Peritoneal Cancer ◽  
Gm Csf ◽  
Platinum Sensitive
Sign in / Sign up

Export Citation Format

Share Document